ArticlePloS one2014
The study of a novel sorafenib derivative HLC-080 as an antitumor agent.
Ke Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticlePloS one2014
Ke Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.